Patients are frustrated that there isn’t a reliable treatment yet for long COVID

Patients are frustrated that there isn’t a reliable treatment yet for long COVID

Publication date: Dec 24, 2024

Instead, the money has mostly gone to research things like how long COVID affects lung function or who gets sick and with what symptoms. What are we trying to treat?BODEN: Horwitz got research money from the NIH to study how long COVID affects people of different ages and ethnicities. Many patients say all that money and research still has not turned up any new therapies. ASMA KHALID, HOST:This month, the National Institutes of Health announced it’s investing $300 million in research treatments for long COVID. Dr. Michael Brode treats long COVID at UT Health Austin, and he prescribes patients off-label medications that sometimes help. Off label means those drugs have been approved by the FDA for other illnesses, but not long COVID. But to do that, there needs to be an understanding of the biological mechanisms that are making people sick, and that’s really hard to do with postinfectious conditions.

Concepts Keywords
Dinner Boden
Migraine Clinical
Npr Covid
Yearly Drugs
Erica
Hayes
Horwitz
Long
Money
Nih
Npr
Sarah
Sick
Treatment
Years

Semantics

Type Source Name
disease MESH long COVID
disease IDO host
disease MESH hives
disease IDO blood
disease MESH migraines
disease IDO symptom

Original Article

(Visited 1 times, 1 visits today)